ACB $1.430 (1.42%)

ACNNF $0.030 (0%)

AERO $3.210 (0%)

ALEAF $0.050 (-14.97%)

AMMJ $0.048 (12.81%)

APHA $15.380 (0%)

ARNA $99.990 (0%)

ATT:CNX $0.080 (0%)

AUSA:CNX $0.065 (0%)

AUSAF $0.050 (0%)

AVXL $11.060 (-0.98%)

BAMM:CNX $0.130 (0%)

BBM:CNX $0.030 (-14.29%)

BBRRF $0.027 (-3.27%)

BE:CNX $0.005 (0%)

BIO:CNX $0.013 (0%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.395 (2.6%)

BLOZF $0.308 (2.5%)

BUDZ $0.100 (-9.09%)

CADMF $0.052 (0%)

CALI:CNX $0.085 (13.33%)

CANN $0.230 (-2.13%)

CARA $9.060 (-6.69%)

CBWTF $0.062 (0.16%)

CGC $2.540 (-0.97%)

CGRW $0.016 (-22%)

CHOO:CNX $0.005 (0%)

CHOOF $0.003 (-16%)

CNBX $3.990 (0%)

CNGGF $0.203 (0%)

CODI $22.680 (0.22%)

CPMD $0.020 (-4.81%)

CRBP $0.281 (0.07%)

CRON $3.050 (0.33%)

CROP:CNX $0.015 (0%)

CSI:CNX $0.070 (-12.5%)

CURR $0.349 (2.65%)

CVSI $0.033 (7.49%)

DIGP $0.014 (0%)

EEVVF $0.078 (0%)

EMHTF $0.039 (10.17%)

EPWCF $0.059 (0%)

FFT:CNX $0.040 (0%)

FNNZF $0.075 (13.64%)

GNBT $0.001 (0%)

GRIN:CNX $0.075 (-16.67%)

GRWG $4.840 (-1.83%)

GTBIF $10.150 (-1.46%)

GTII:CNX $13.090 (-1.65%)

GWPH $218.960 (0%)

HEXO $0.196 (-0.56%)

HHPHF $0.079 (0%)

HLSPY $0.363 (0%)

HMLSF $2.800 (0%)

HMPPF $0.498 (0%)

HRVOF $0.023 (-11.07%)

HSTRF $0.135 (0%)

HUGE:CNX $1.180 (-1.67%)

IAN:CNX $0.075 (0%)

IGC $0.520 (-3.02%)

IGXT $0.219 (13.76%)

IIPR $92.910 (-2.5%)

INQD $0.009 (-3.23%)

IONC:CNX $0.005 (0%)

IONKF $0.005 (-2.04%)

ISOL:CNX $0.035 (0%)

ITHUF $0.062 (5.65%)

KBEV:CNX $0.045 (0%)

KHRNF $0.091 (-2.15%)

KSHB $0.695 (0%)

LHS:CNX $1.470 (0%)

LHSIF $1.145 (0%)

LXX:CNX $8.400 (0%)

MCIG $0.028 (0%)

MEDIF $0.057 (1.15%)

MGWFF $0.060 (9.57%)

MJ:CNX $0.050 (0%)

MJNA $0.015 (1.4%)

MNTR $0.040 (0%)

MYM:CNX $0.140 (0%)

MYMMF $0.106 (0%)

NCNNF $0.058 (0%)

NDVAF $0.111 (-6.17%)

NGW:CNX $0.410 (0%)

NRXCF $0.035 (0%)

NSPDF $0.010 (-23.53%)

NVTQF $0.596 (0%)

NWKRF $0.424 (0%)

NXGWF $0.316 (0%)

NXTTF $0.033 (6.61%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

PHCG $0.001 (0%)

PHVAF $0.038 (0%)

PILL:CNX $0.230 (-17.86%)

PKG:CNX $0.020 (-20%)

PLPRF $0.357 (0%)

PLUS:CNX $0.440 (0%)

PMCB $2.420 (0%)

PNPL $0.012 (0%)

PTNYF $0.018 (3.24%)

QCA:CNX $0.095 (-5%)

RDDTF $0.020 (1.53%)

RLLVF $0.001 (0%)

RMHB $0.028 (2.8%)

RQB:CNX $0.005 (0%)

RQHTF $0.448 (2.99%)

SLNG:CNX $0.095 (-9.52%)

SMG $83.180 (-1.21%)

SNN:CNX $0.155 (0%)

SOL:CNX $0.320 (0%)

SOLCF $0.250 (0%)

SPLIF $0.016 (-15.79%)

SPRWF $0.268 (0%)

STEM:CNX $0.035 (0%)

STMH $0.028 (1.45%)

SUN:CNX $0.150 (0%)

TBPMF $0.052 (3.82%)

TCAN:CNX $0.135 (0%)

TCNAF $0.080 (0%)

TER:CNX $3.480 (-0.57%)

TGEN $1.200 (0%)

TGIF:CNX $0.025 (-16.67%)

TGIFF $0.020 (-12.28%)

THC:CNX $0.048 (0%)

THCBF $0.044 (12.85%)

TLRY $3.540 (1.14%)

TRLFF $0.035 (0%)

TRSSF $2.710 (0.37%)

TURV $0.001 (0%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.015 (0%)

VPRB $0.047 (-6%)

VRTHF $0.026 (0%)

VVCIF $0.035 (-8.14%)

WAYL:CNX $0.740 (0%)

XXII $1.740 (-12.12%)

ZDPY $0.740 (-2.63%)

ZYNE $1.190 (-0.83%)

Technical420 Site Search

Returned 56 result(s).

Tilray Is Facing Several Lawsuits From Investors Via Their Most Recent 8-K Filing

After the market closed on Friday, Tilray, Inc. (TLRY) filed two important documents with the US Securities Exchange Commission (SEC) as it relates to the previously announced merger agreement with Aphria Inc. (APHA.TO) (APHA). When the agreement was announced, the market responded favorably and both Aphria and Tilray bounced higher.…

Aphria and Tilray’s Combined European Footprint Will Give Them A Massive Advantage Over The Incoming Competition

During the last year, we have noticed a transformational change with the legal cannabis sector and noticed that Canadian Licensed Producers (LPs) were becoming highly focused on the cannabis opportunity in the European Union (EU) and the United States (US).  Last week, we highlighted a few leading Canadian LPs that…

Breaking Down the Aphria-Tilray Merger. What Do Canadian Investors Get?

Next month, Aphria Inc. (APHA.TO) (APHA) will hold a special shareholder meeting to vote on the previously announced merger with Tilray, Inc. (TLRY).  This has been a hot topic of discussion and the market has responded favorably to the potential mega-merger. We believe the combined company will have an attractive…

3 Canadian Licensed Producers With Assets Ready To Capitalize On The U.S. Cannabis Market

In the early months of the COVID pandemic, many people questioned the future of the cannabis industry. After the sector was declared to be an essential industry, many US operators were able to breathe a sigh of relief. The US cannabis sector will come out of the pandemic stronger than…

Is Aphria/Tilray The Best Suited Canadian LP To Capitalize On The U.S Upon Federal Legalization?

With New York on the verge of legalizing recreational cannabis, we have seen an influx in questions concerning the US cannabis market. The US cannabis industry was the biggest winner of the 2020 general election and has been receiving much more mainstream media coverage since then. The combination of 8…

3 Major Emerging Cannabis Markets Investors Need To Closely Watch In 2021

One of the most significant trends in the cannabis industry involves international markets and this is a vertical that we are bullish on. Going forward, we expect international markets to serve as a substantial growth catalyst for companies that are levered to this sector of the industry and this is…

Technical420 Deep Dive: There Is Still A Ton Of Value For Investors To Extract From The Cannabis Oil Trade

During the last year, the cannabis industry has recorded impressive growth as new markets open across the globe.  The opening of new markets has led to an increase in the number of export agreements, and this has greatly benefitted Canadian cannabis companies. One of the most attractive aspects of this…

Here Is What Will Be Decided At The Aphria & Tilray “MegaMerger” Meeting Next Month

Next month, Aphria Inc. (TSX: APHA) (Nasdaq: APHA) will have a special shareholder meeting to vote on the previously announced merger with Tilray, Inc. (Nasdaq: TLRY). We expect shareholders to approve the business combination and believe the market has already priced in this outcome. During the last month, both Aphria…

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, are pleased to announce that: (i) Aphria has obtained an interim order (the " Interim Order ") of the Ontario Superior Court of Justice (Commercial List) (the " Court ") in connection with its proposed business combination with…

Aphria and Tilray Are Set To Benefit In A Major Way From The Rapidly Evolving Regulatory Framework In The United States

In any emerging market, one of the best ways to assess the progress of a new industry is through Wall Street analyst coverage. The cannabis sector is a prime example as we have seen a steady increase in the number of banks that are covering the industry. Although a majority…

« Newer PostsOlder Posts »

Search Again